Kyle de la Cena is an accomplished professional in clinical operations, currently serving as Associate Director at PathAI since November 2024, having previously held various roles within the company from 2022 to 2024. With extensive experience leading clinical trials and managing operations for preclinical studies, Kyle has successfully overseen 70+ studies across multiple imaging modalities at Invicro. Academic qualifications include a Master of Science in Pathology and Laboratory Medicine from Boston University and a Bachelor’s Degree in Biological Sciences from UC Irvine. Additional experience includes impactful positions at Boston Medical Center, Boston University, and Pathnostics, demonstrating a strong foundation in research, data management, and laboratory operations.
This person is not in any teams
This person is not in any offices